A record of what Vaishali Parekh said publicly, with the source. Not advice.
“Recommends buying Glenmark Pharmaceuticals at ₹2049, targeting ₹2200, with a stop loss at ₹1960.”
Vaishali Parekh’s track record (trackable calls only): 742 graded calls · 95% CI 30–37%
How this call is judged
A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.
Entry: ₹2,049, as stated.
Target ₹2,200, stop ₹1,960, as stated.
No time frame is stated, so it is tracked until a close reaches ₹2,200 or ₹1,960: there is no fixed window.
The stop ₹1,960 was reached on a close before the target ₹2,200. Miss.
The grader’s working: R3 TRADE_SETUP: entered ₹2049 on 2025-09-09 (stated entry ₹2049, LEVEL_CMP entry, filled); stop ₹1960 breached at close ₹1958.2 on 2025-09-29. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.
How it played out
How this is worked out- Target or stop first
- The stop was reached on a close before the target was.
- Time to target
- The target was not reached on a close before the stop was.
- Worst close against it
- The closing price went as far as 4.43% against the call up to 29 Sep 2025, when the call was decided, measured from the entry price. Closing prices only; an intraday dip is never counted.
From the entry the grade used, on closing prices. This is a record of one past call and is not advice.